Aurobindo's combo AIDS drug gets tentative FDA OK

06/28/2013 | Business Standard (India)

The FDA gave tentative approval for Aurobindo Pharma's combination drug efavirenz+lamivudine+tenofovir to treat AIDS. The combination, which can be used by itself or with other antiretrovirals, is indicated for adult HIV-1 patients, as well as for adolescents older than 16 who weigh more than 88 pounds.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI